Application

18487254 · Crystal Forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)-pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

Filed 2023-10-16 · Abandoned The official file ↗ · Art unit 1624 · Examiner Douglas M Willis Typical · CPC C07D 487/04 · Acerta Pharma B.V. · Morgan, Lewis & Bockius LLP (Acerta)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

14.6 mo

to disposition 30.2 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.